These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28621319)

  • 1. FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate.
    Park JW; Lee JK; Witte ON; Huang J
    Mod Pathol; 2017 Sep; 30(9):1262-1272. PubMed ID: 28621319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2.
    Liu Q; Pang J; Wang LA; Huang Z; Xu J; Yang X; Xie Q; Huang Y; Tang T; Tong D; Liu G; Wang L; Zhang D; Ma Q; Xiao H; Lan W; Qin J; Jiang J
    J Pathol; 2021 Jan; 253(1):106-118. PubMed ID: 33009820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
    Gupta A; Wang Y; Browne C; Kim S; Case T; Paul M; Wills ML; Matusik RJ
    Prostate; 2008 Jan; 68(1):50-60. PubMed ID: 18004726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate.
    Xin Z; Zhang Y; Jiang Z; Zhao L; Fan L; Wang Y; Xie S; Shangguan X; Zhu Y; Pan J; Liu Q; Huang Y; Dong B; Xue W
    Hum Pathol; 2018 Sep; 79():151-159. PubMed ID: 29885405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2.
    Gupta A; Yu X; Case T; Paul M; Shen MM; Kaestner KH; Matusik RJ
    Prostate; 2013 May; 73(6):582-9. PubMed ID: 23060003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer.
    Han M; Li F; Zhang Y; Dai P; He J; Li Y; Zhu Y; Zheng J; Huang H; Bai F; Gao D
    Cancer Cell; 2022 Nov; 40(11):1306-1323.e8. PubMed ID: 36332622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PC3 is a cell line characteristic of prostatic small cell carcinoma.
    Tai S; Sun Y; Squires JM; Zhang H; Oh WK; Liang CZ; Huang J
    Prostate; 2011 Nov; 71(15):1668-79. PubMed ID: 21432867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
    Simon RA; di Sant'Agnese PA; Huang LS; Xu H; Yao JL; Yang Q; Liang S; Liu J; Yu R; Cheng L; Oh WK; Palapattu GS; Wei J; Huang J
    Hum Pathol; 2009 Feb; 40(2):252-8. PubMed ID: 18835619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siah2-dependent concerted activity of HIF and FoxA2 regulates formation of neuroendocrine phenotype and neuroendocrine prostate tumors.
    Qi J; Nakayama K; Cardiff RD; Borowsky AD; Kaul K; Williams R; Krajewski S; Mercola D; Carpenter PM; Bowtell D; Ronai ZA
    Cancer Cell; 2010 Jul; 18(1):23-38. PubMed ID: 20609350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma.
    Li W; Cohen A; Sun Y; Squires J; Braas D; Graeber TG; Du L; Li G; Li Z; Xu X; Chen X; Huang J
    Mol Cancer Res; 2016 Apr; 14(4):344-53. PubMed ID: 26832214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P63 expression in lung carcinoma: a tissue microarray study of 408 cases.
    Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of prostatic small-cell neuroendocrine carcinoma.
    Clegg N; Ferguson C; True LD; Arnold H; Moorman A; Quinn JE; Vessella RL; Nelson PS
    Prostate; 2003 Apr; 55(1):55-64. PubMed ID: 12640661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Models of neuroendocrine prostate cancer.
    Berman-Booty LD; Knudsen KE
    Endocr Relat Cancer; 2015 Feb; 22(1):R33-49. PubMed ID: 25349195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of neuroendocrine acquisition and biomarker expression between neuroendocrine and usual prostatic carcinoma.
    Xiao GQ; Ho G; Suen C; Hurth KM
    Prostate; 2021 Jun; 81(8):469-477. PubMed ID: 33848377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and characterization of a novel treatment-related neuroendocrine prostate cancer cell line KUCaP13.
    Okasho K; Mizuno K; Fukui T; Lin YY; Kamiyama Y; Sunada T; Li X; Kimura H; Sumiyoshi T; Goto T; Kobayashi T; Lin D; Wang Y; Collins CC; Inoue T; Ogawa O; Akamatsu S
    Cancer Sci; 2021 Jul; 112(7):2781-2791. PubMed ID: 33960594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 Loss Distinguishes Prostatic Small-Cell Carcinoma from Most Prostatic Adenocarcinomas.
    Tsai H; Morais CL; Alshalalfa M; Tan HL; Haddad Z; Hicks J; Gupta N; Epstein JI; Netto GJ; Isaacs WB; Luo J; Mehra R; Vessella RL; Karnes RJ; Schaeffer EM; Davicioni E; De Marzo AM; Lotan TL
    Clin Cancer Res; 2015 Dec; 21(24):5619-29. PubMed ID: 26246306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of YAP1 is increased in high-grade prostatic adenocarcinoma but is reduced in neuroendocrine prostate cancer.
    Cheng S; Prieto-Dominguez N; Yang S; Connelly ZM; StPierre S; Rushing B; Watkins A; Shi L; Lakey M; Baiamonte LB; Fazili T; Lurie A; Corey E; Shi R; Yeh Y; Yu X
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):661-669. PubMed ID: 32313141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-cell neuroendocrine carcinoma of the prostate: are heterotransplants a better experimental model?
    Lopez-Barcons LA
    Asian J Androl; 2010 May; 12(3):308-14. PubMed ID: 20023690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.